Veradigm Inc. (NASDAQ:MDRX – Get Free Report)’s share price gapped down prior to trading on Monday . The stock had previously closed at $10.21, but opened at $9.75. Veradigm shares last traded at $10.00, with a volume of 4,082 shares traded.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on shares of Veradigm in a research note on Wednesday, December 11th. They set a “hold” rating for the company. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $11.75.
View Our Latest Stock Report on MDRX
Veradigm Stock Down 2.7 %
Hedge Funds Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- What is the Nikkei 225 index?
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Overbought Stocks Explained: Should You Trade Them?
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- How Investors Can Find the Best Cheap Dividend Stocks
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.